Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Combinatorial genetic technology for the development of new anti-infectives.

Laios E, Waddington M, Saraiya AA, Baker KA, O'Connor E, Pamarathy D, Cunningham PR.

Arch Pathol Lab Med. 2004 Dec;128(12):1351-9. Review.

PMID:
15578878
[PubMed - indexed for MEDLINE]
2.

Aminoacyl-tRNA synthetases: essential and still promising targets for new anti-infective agents.

Ochsner UA, Sun X, Jarvis T, Critchley I, Janjic N.

Expert Opin Investig Drugs. 2007 May;16(5):573-93. Review.

PMID:
17461733
[PubMed - indexed for MEDLINE]
3.

Anti-infectives in the 21st century.

Clough J.

Drug Discov Today. 2002 Oct 15;7(20):1036-8. No abstract available.

PMID:
12546891
[PubMed - indexed for MEDLINE]
4.

Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.

Horcajada JP, Vila J, Moreno-Martínez A, Ruiz J, Martínez JA, Sánchez M, Soriano E, Mensa J.

J Antimicrob Chemother. 2002 Jan;49(1):55-9.

PMID:
11751767
[PubMed - indexed for MEDLINE]
Free Article
5.

Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach.

Chalker AF, Lunsford RD.

Pharmacol Ther. 2002 Jul;95(1):1-20. Review.

PMID:
12163125
[PubMed - indexed for MEDLINE]
6.

Controlling mutation: intervening in evolution as a therapeutic strategy.

Cirz RT, Romesberg FE.

Crit Rev Biochem Mol Biol. 2007 Sep-Oct;42(5):341-54. Review.

PMID:
17917871
[PubMed - indexed for MEDLINE]
7.

Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli.

Qiang YZ, Qin T, Fu W, Cheng WP, Li YS, Yi G.

J Antimicrob Chemother. 2002 Mar;49(3):549-52.

PMID:
11864958
[PubMed - indexed for MEDLINE]
Free Article
8.

In vitro system for high-throughput screening of random peptide libraries for antimicrobial peptides that recognize bacterial membranes.

Xie Q, Matsunaga S, Wen Z, Niimi S, Kumano M, Sakakibara Y, Machida S.

J Pept Sci. 2006 Oct;12(10):643-52.

PMID:
16878349
[PubMed - indexed for MEDLINE]
9.

Genes and mutations conferring antimicrobial resistance in Salmonella: an update.

Michael GB, Butaye P, Cloeckaert A, Schwarz S.

Microbes Infect. 2006 Jun;8(7):1898-914. Epub 2006 Mar 23. Review.

PMID:
16716631
[PubMed - indexed for MEDLINE]
10.

The British Pharmaceutical Conference 2009. 6-9 September 2009, Manchester, UK.

Uchegbu I.

IDrugs. 2009 Nov;12(11):683-5.

PMID:
19844851
[PubMed - indexed for MEDLINE]
11.

Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori.

Tsugawa H, Suzuki H, Muraoka H, Ikeda F, Hirata K, Matsuzaki J, Saito Y, Hibi T.

Biochem Biophys Res Commun. 2011 Jan 14;404(2):656-60. doi: 10.1016/j.bbrc.2010.12.034. Epub 2010 Dec 11.

PMID:
21147064
[PubMed - indexed for MEDLINE]
12.

Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis.

Lobritz M, Hutton-Thomas R, Marshall S, Rice LB.

Antimicrob Agents Chemother. 2003 Oct;47(10):3318-20.

PMID:
14506047
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Molecular basis of quinolone resistance in Escherichia coli from wild birds.

Jiménez Gómez PA, García de los Rios JE, Rojas Mendoza A, de Pedro Ramonet P, García Albiach R, Reche Sainz MP.

Can J Vet Res. 2004 Jul;68(3):229-31.

PMID:
15352551
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Discontinued drugs in 2006: anti-infectives.

Ryder NS.

Expert Opin Investig Drugs. 2007 Dec;16(12):1867-78. Review.

PMID:
18041997
[PubMed - indexed for MEDLINE]
15.

Anti-infectives-induced adverse drug reactions in hospitalized patients.

Gholami K, Parsa S, Shalviri G, Sharifzadeh M, Assasi N.

Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):501-6.

PMID:
15844215
[PubMed - indexed for MEDLINE]
16.

Mistranslation induced by streptomycin provokes a RecABC/RuvABC-dependent mutator phenotype in Escherichia coli cells.

Balashov S, Humayun MZ.

J Mol Biol. 2002 Jan 25;315(4):513-27.

PMID:
11812126
[PubMed - indexed for MEDLINE]
17.

Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics.

Obrecht D, Robinson JA, Bernardini F, Bisang C, DeMarco SJ, Moehle K, Gombert FO.

Curr Med Chem. 2009;16(1):42-65. Review.

PMID:
19149562
[PubMed - indexed for MEDLINE]
18.

Combinatorial chemistry in anti-infectives research.

Wijkmans JC, Beckett RP.

Drug Discov Today. 2002 Jan 15;7(2):126-32. Review.

PMID:
11790623
[PubMed - indexed for MEDLINE]
19.

Emergence of the plasmid-mediated quinolone resistance gene qnrS1 in Escherichia coli isolates in Greece.

Vasilaki O, Ntokou E, Ikonomidis A, Sofianou D, Frantzidou F, Alexiou-Daniel S, Maniatis AN, Pournaras S.

Antimicrob Agents Chemother. 2008 Aug;52(8):2996-7. doi: 10.1128/AAC.00325-08. Epub 2008 May 19. No abstract available.

PMID:
18490503
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli.

Hänninen ML, Hannula M.

J Antimicrob Chemother. 2007 Dec;60(6):1251-7. Epub 2007 Oct 2.

PMID:
17911389
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk